Pyrimidine: a review on anticancer activity with key emphasis on SAR

被引：99
作者：
Mahapatra, Aastha [1 ]
Prasad, Tanya [1 ]
Sharma, Tripti [1 ]
机构：
[1] Siksha O Anusandhan, Fac Pharmaceut Sci, Dept Med Chem, Bhubaneswar 751003, Odisha, India
来源：
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES | 2021年 / 7卷 / 01期
关键词：
Pyrimidine; Anticancer activity; Structure activity relationship; Heterocyclic compounds; APOPTOSIS-INDUCING ABILITY; VITRO ANTITUMOR EVALUATION; CYCLIN-DEPENDENT KINASES; ANTI-BREAST CANCER; BIOLOGICAL EVALUATION; IN-VITRO; DERIVATIVES BEARING; POTENT ANTITUMOR; ANTIPROLIFERATIVE ACTIVITY; TYROSINE KINASE;
D O I：
10.1186/s43094-021-00274-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background Cancer is a global health challenge, it impacts the quality of life and its treatment is associated with several side effects. Resistance of the cancer cells to the existing drugs has led to search for novel anticancer agents. Pyrimidine, a privileged scaffold, is part of living organisms and plays vital role in various biological procedures as well as in cancer pathogenesis. Due to resemblance in structure with the nucleotide base pair of DNA and RNA, it is recognized as valuable compound in the treatment of cancer. Main text Many novel pyrimidine derivatives have been designed and developed for their anticancer activity in the last few years. The present review aims to focus on the structure activity relationship (SAR) of pyrimidine derivatives as anticancer agent from the last decade. Conclusion This review intends to assist in the development of more potent and efficacious anticancer drugs with pyrimidine scaffold.
引用
收藏
页数：38
相关论文
共 148 条
[71]   Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents [J].
Kumar, R. Naresh ;
Dev, G. Jitender ;
Ravikumar, N. ;
Swaroop, D. Krishna ;
Debanjan, B. ;
Bharath, G. ;
Narsaiah, B. ;
Jain, S. Nishant ;
Rao, A. Gangagni .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (12) :2927-2930
[72]   Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents [J].
Kumar, Royya Naresh ;
Poornachandra, Yedla ;
Nagender, Punna ;
Mallareddy, Gannarapu ;
Kumar, Nagiri Ravi ;
Ranjithreddy, Palreddy ;
Kumar, Chityal Ganesh ;
Narsaiah, Banda .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 108 :68-78
[73]   Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity [J].
Kurumurthy, C. ;
Rao, P. Sambasiva ;
Swamy, B. Veera ;
Kumar, G. Santhosh ;
Rao, P. Shanthan ;
Narsaiah, B. ;
Velatooru, L. R. ;
Pamanji, R. ;
Rao, J. Venkateswara .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (08) :3462-3468
[74]   An unexpected Dimroth rearrangement leading to annelated thieno [3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity [J].
Lauria, Antonino ;
Patella, Chiara ;
Abbate, Ilenia ;
Martorana, Annamaria ;
Almerico, Anna Maria .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 :381-388
[75]   New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol [J].
Lauria, Antonino ;
Abbate, Ilenia ;
Patella, Chiara ;
Martorana, Annamaria ;
Dattolo, Gaetano ;
Almerico, Anna Maria .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :416-424
[76]   Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity [J].
Lee, Ho Jin ;
Pham, Phuong Chi ;
Hyun, Seung Yeob ;
Baek, Byungyeob ;
Kim, Byungjin ;
Kim, Yunha ;
Min, Hye-Young ;
Lee, Jeeyeon ;
Lee, Ho-Young .
MOLECULAR CANCER, 2018, 17
[77]   Design, synthesis, and biological evaluation of thieno[2,3-d]pyrimidine derivatives as novel dual c-Met and VEGFR-2 kinase inhibitors [J].
Li, Jieming ;
Gu, Weijie ;
Bi, Xinzhou ;
Li, Huilan ;
Liao, Chen ;
Liu, Chunxia ;
Huang, Wenlong ;
Qian, Hai .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (24) :6674-6679
[78]   Design, synthesis and antiproliferative activity of thiazolo[5,4-d] pyrimidine derivatives through the atom replacement strategy [J].
Li, Zhong-Hua ;
Liu, Xue-Qi ;
Geng, Peng-Fei ;
Zhang, Ji ;
Ma, Jin-Lian ;
Wang, Bo ;
Zhao, Tao-Qian ;
Zhao, Bing ;
Zhang, Xin-Hui ;
Yu, Bin ;
Liu, Hong-Min .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :1034-1041
[79]   Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy [J].
Li, Zhong-Hua ;
Zhang, Ji ;
Liu, Xue-Qi ;
Geng, Peng-Fei ;
Ma, Jin-Lian ;
Wang, Bo ;
Zhao, Tao-Qian ;
Zhao, Bing ;
Wei, Hao-Ming ;
Wang, Chao ;
Fu, Dong-Jun ;
Yu, Bin ;
Liu, Hong-Min .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 135 :204-212
[80]   Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors [J].
Li, Zhong-Hua ;
Liu, Xue-Qi ;
Geng, Peng-Fei ;
Suo, Feng-Zhi ;
Ma, Jin-Lian ;
Yu, Bin ;
Zhao, Tao-Qian ;
Zhou, Zhao-Qing ;
Huang, Chen-Xi ;
Zheng, Yi-Chao ;
Liu, Hong-Min .
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (04) :384-389
3456789101112